Simarjot Pabla

563 total citations
8 papers, 451 citations indexed

About

Simarjot Pabla is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Simarjot Pabla has authored 8 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Simarjot Pabla's work include CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (3 papers). Simarjot Pabla is often cited by papers focused on CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (3 papers). Simarjot Pabla collaborates with scholars based in United States, India and Taiwan. Simarjot Pabla's co-authors include Michał Seweryn, Grzegorz A. Rempała, Paweł Kisielow, Richard McIndoe, Leszek Ignatowicz, Anna Cebula, Lynn Bry, Piotr Kraj, Timothy L. Denning and Mohamed Uduman and has published in prestigious journals such as Nature, Nature Communications and Blood.

In The Last Decade

Simarjot Pabla

8 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simarjot Pabla United States	6	278	179	129	54	47	8	451
Martina Rocchi Italy	7	169 0.6×	167 0.9×	60 0.5×	26 0.5×	67 1.4×	11	398
Anja Bubke Germany	13	383 1.4×	79 0.4×	119 0.9×	28 0.5×	28 0.6×	15	518
Adam W. Plumb Canada	9	232 0.8×	104 0.6×	100 0.8×	21 0.4×	27 0.6×	11	420
Kenta Narumi Japan	12	200 0.7×	119 0.7×	174 1.3×	12 0.2×	54 1.1×	23	391
Travis J. Friesen United States	8	238 0.9×	151 0.8×	162 1.3×	25 0.5×	37 0.8×	10	502
Yukihisa Sawa Japan	6	293 1.1×	84 0.5×	90 0.7×	15 0.3×	36 0.8×	9	431
Ilko Kastirr Italy	6	272 1.0×	74 0.4×	68 0.5×	39 0.7×	28 0.6×	6	389
Georgi S. Angelov Switzerland	12	457 1.6×	155 0.9×	95 0.7×	25 0.5×	20 0.4×	16	587
Claire Willis United Kingdom	10	334 1.2×	89 0.5×	103 0.8×	22 0.4×	68 1.4×	11	444
Changsoo Kwak United States	3	169 0.6×	90 0.5×	57 0.4×	27 0.5×	32 0.7×	4	283

Countries citing papers authored by Simarjot Pabla

Since Specialization

Citations

This map shows the geographic impact of Simarjot Pabla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simarjot Pabla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simarjot Pabla more than expected).

Fields of papers citing papers by Simarjot Pabla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simarjot Pabla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simarjot Pabla. The network helps show where Simarjot Pabla may publish in the future.

Co-authorship network of co-authors of Simarjot Pabla

This figure shows the co-authorship network connecting the top 25 collaborators of Simarjot Pabla. A scholar is included among the top collaborators of Simarjot Pabla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simarjot Pabla. Simarjot Pabla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Skeate, Joseph G., Walker S. Lahr, Nicholas J. Slipek, et al.. (2022). 392 Engineering CD70-directed CAR-NK cells for the treatment of hematological and solid malignancies. Regular and Young Investigator Award Abstracts. A413–A413. 1 indexed citations

2.

Choi, Eugene, Walker S. Lahr, Emily J. Pomeroy, et al.. (2021). Engineering CD70-Directed CAR-NK Cells for the Treatment of Hematological and Solid Malignancies. Blood. 138(Supplement 1). 1691–1691. 20 indexed citations

3.

Tanne, Antoine, Simarjot Pabla, Sudesh Pawaria, et al.. (2020). Abstract 922: Expanding the therapeutic potential of anti-PD-1 and anti-CTLA-4 therapy with innovative Fc engineering and rationale combinations for the treatment of solid tumors. Cancer Research. 80(16_Supplement). 922–922. 1 indexed citations

4.

Castle, John C., Mohamed Uduman, Simarjot Pabla, Robert B. Stein, & Jennifer S. Buell. (2019). Mutation-Derived Neoantigens for Cancer Immunotherapy. Frontiers in Immunology. 10. 1856–1856. 89 indexed citations

5.

Guo, Dehuang, Qinqin Xu, Sarabjot Pabla, et al.. (2018). Cytokeratin-8 in Anaplastic Thyroid Carcinoma: More Than a Simple Structural Cytoskeletal Protein. International Journal of Molecular Sciences. 19(2). 577–577. 12 indexed citations

6.

Wojciech, Łukasz, Michał Seweryn, Grzegorz A. Rempała, et al.. (2014). The same self-peptide selects conventional and regulatory CD4+ T cells with identical antigen receptors. Nature Communications. 5(1). 5061–5061. 16 indexed citations

7.

Cebula, Anna, Michał Seweryn, Grzegorz A. Rempała, et al.. (2013). Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature. 497(7448). 258–262. 305 indexed citations

8.

Pabla, Simarjot & Sarabjot Pabla. (2008). Real-time polymerase chain reaction. Resonance. 13(4). 369–377. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact